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Introduction
Background. High glucose concentration, through the activation of calcium channels, augments in vitro cal-An elevation in the basal levels of cytosolic calcium cium entry into cells and leads to elevation in the basal ([Ca2+] i ) has been observed in many cells of patients levels of [Ca2+] i , the latter causes cell dysfunction. with diabetes mellitus [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . This derangement has Design of study. The present study examined whether been incriminated in the genesis of diabetic complicastreptozotocin-induced diabetes mellitus in rats causes tions [8 ] . Indeed, Alexiewicz et al. [9] reported an a rise in [Ca2+] i of PMNL and impairs their phagocyt-elevation in basal levels of [Ca2+] i of polymorphonuosis and whether treatment of these rats with the clear leucocytes (PMNL) of patients with type II calcium channel blocker, amlodipine, prevents and/or diabetes mellitus, and this change in [Ca2+] i appeared reverses these derangements. Amlodipine was given to be responsible for the impairment in their phagocyteither from day one of diabetes or after 3 or 12 days osis. is responsible, in major part, The present study examined the effect of the calcium for the impaired phagocytosis but other factors are channel blocker, amlodipine, on the in vitro glucosealso operative; and (iv) calcium channel blockers could mediated rise in [Ca2+] i of PMNL as well as its in vivo prove useful in the treatment of the metabolic and effect on [Ca2+] i of these cells and on their phagocytic functional derangements of PMNL in patients with property in rats rendered diabetic by streptozotocin. poorly controlled diabetes.
i.p. injection of freshly prepared streptozotocin dis-each experiment and was not found to be a significant factor. Maximal fluorescence (F max ) and minimal fluosolved in citrate-phosphate buffer, pH 4.4. The rats rescence (F min ) were measured with 0.05% Triton and were fed normal rat chow diet ( Wayne Research 5 mM EGTA in Tris base buffer ( pH 8.0), respectively. Animal Diets, Chicago, IL), and were allowed free Calculation of [Ca2+] i was done using the Grynkiewicz, access to water. Their water intake increased significPoenie and Tsien equation [14] , and the dissociation antly after the induction of diabetes. Before the injecconstant for Ca2+-Fura 2 was assumed to be 225 nM. tion of streptozotocin, the rats drank 28±1.1 ml/day; Phagocytosis of PMNL was estimated spectrophototheir water intake increased to 45±3.4 ml/day after 1 metrically by measuring the rate of ingestion by PMNL day of hyperglycaemia and to 68±7.1 ml, 90±10.6 ml, according to the bioassay described by Southwick and and 271±7.3 ml per day after 2, 3, and 12 days of Stossel [15 ] . Briefly, PMNL were fed oil droplets diabetes, respectively.
containing oil red O and coated with Escherichia coli On the day of the study, the rats were put lipopolysaccharide (2 mg per experiment). These parunder light anesthesia by i.p. injection of 4 mg ticles were previously opsonized in fresh autologous pentobarbital/100 g b.w., and blood was drawn directly serum. After the PMNL and the particles were incubfrom the heart under sterile conditions. The blood was ated for 5 min at 37°C, the reaction was rapidly stopped placed into sterile test tubes containing 100 U of preserby adding ice-cold isotonic saline that contained vative free heparin (Gibco Laboratories, Grand Island, 1 mmol/l N-ethyl-maleimide, which poisons the cells New York, USA) per 1 ml of blood. PMNL were and blocks ingestion. Uningested particles were separisolated from whole blood according to the method ated from cells that contained ingested particles by described by Ferrante and Thong [13] with modificacentrifugation at 250 g for 10 min. Oil red O was tion. A total of 3.0 ml of fresh heparinized blood was extracted from the cell pellet with dioxane, and the placed over two layers of Ficoll-Hypaque solution in optical density of the extract was measured using a 15 ml conical polypropylene tubes. The bottom layer Perkin Elmer Lambda 2 UV/VIS spectrophotometer was made of 3 ml Mono-Poly Resolving Medium with (Perkin Elmer, Norwalk, CT ) at a wavelength of density of 1.114 g/ml ( Flow Laboratories, Inc., 525 nm. The ingestion rate was expressed in microgMcLean, Virginia, USA) and a second layer of 1.0 ml rams of oil engulfed per 107 PMNL/min. All reagents of Isolymph with density of 1.077 g/ml (Gallardfor this assay were purchased from Aldrich Chemical Schlesinger Industries, Inc., Carle Place, New York, (Milwaukee, Wisconsin). Lipopolysaccharide E. coli USA). The tubes were centrifuged at 1270 g for 45 min 026:B6 was obtained from Bovin preparation (Difco at room temperature. This procedure resulted in the Laboratories, Detroit, Michigan). separation of mononuclear and polymorphonuclear Both in vitro and in vivo studies were performed. In cells into two distinct bands with the red blood cell the in vitro studies we examined the effect of 30 mM pellet at the bottom of the tube. The PMNL were glucose or choline chloride with and without amlodipaspirated with Pasteur pipette and washed twice in ine (1, 2, 3, 4 mM ) on [Ca2+] i and phagocytosis of Hank's balanced salt solution (HBSS ). Cells from two PMNL. These cells were incubated with appropriate animals were pooled for each study. Cell purity, as media for varying periods of time ( 5, 15, 30, and determined by Wright's staining, was >97% and cell 60 min). Also the effect of amlodipine alone on [Ca2+] i viability assayed by the Trypan blue exclusion method and phagocytosis of PMNL of normal rats were evaluexceeded 98%.
ated. We based the choice of 30 mM glucose on our Resting levels of [Ca2+] i of the PMNL were estimated previous studies which showed a glucose-dependent with Fura 2-AM (Sigma Chemical Co., St Louis, MO, increase in [Ca2+] i , with 30 mM of glucose producing USA). A sample of 5×106 PMNL was washed with 30% increase in [Ca2+] i
[12]. solution I containing in mM: NaCl, 132; KCl, 3;
In the in vivo studies, we first examined the effect of MgSo 4 , 1; NaH 2 PO 4 , 1.2; -glucose, 10; Hepes, 10; various doses of streptozotocin (30, 35, 40, and CaCl 2 , 0.02 (pH was adjusted to 7.4 with Tris buffer) 50 mg/kg b.w.) for a period of 12 days to determine and spun at 300 g for 15 min. The pellet was resus-the dosage and time relationship between streptozotopended in 490 ml of the above solution and 10 ml of cin and blood glucose. There was significant variability Fura 2-AM dissolved in DMSO giving a final concen-among the different rats. As shown in Figure 1 , the tration of 4 mM of Fura 2-AM. The mixture was then dose of 50 mg/kg body weight produced early hyperincubated in water bath at 37°C for 30 min. After this glycaemia which was maintained throughout the 12 incubation, the cells were washed and resuspended in days of the study. We therefore used 50 mg of solution I. Measurements of [Ca2+] i were done with streptozotocin/kg b.w. in all of the subsequent studies. Perkin Elmer fluorescence spectrophotometer Model These included the effect of 1, 2, 3, and 12 days of LS 5B (Perkin Elmer, CT, USA) at excitation wave-hyperglycaemia with and without s.c. injection of length of 340 nm and 380 nm and emission wavelength 0.10 mg amlodipine/g b.w. twice daily on [Ca2+] i and of 510 nm, with a slit of 10 and 20 mm, respectively. phagocytosis of the PMNL. The dose of 0.20 mg of An aliquot of 100 ml of PMNL suspension was added amlodipine/g b.w./day was chosen since preliminary to a spectrophotometer cuvette containing 1.9 ml of studies showed that a dose of 0.15 mg/g/day did not solution II, which was the same as solution I except affect the hyperglycaemia-induced rise in [Ca2+] i
. In for a 1 mM CaCl 2 concentration. Autofluorescence part of the studies, amlodipine was given on the same day in which streptozotocin was injected and a daily from cells and/or added reagents was monitored during glucose on [Ca2+] i of PMNL is related to its osmotic activity. When these studies were done in the presence administration of amlodipine continued throughout of amlodipine, this agent inhibited in a dose dependent the study. In another set of experiments, amlodipine manner the glucose or choline chloride-induced rise in therapy was began after 3 or 12 days of the streptozoto-[Ca2+]
i of the PMNL (Figure 2 ) . Also, the time cin injection to determine whether the calcium channel dependent glucose-induced rise in [Ca2+] i of the blocker can reverse the already established derange-PMNLs was inhibited in a dose-dependent manner by ments of [Ca2+] i and phygocotosis of PMNL. In these amlodipine (Figure 3 ) . experiments, the 3 or 12 days diabetic rats were divided
We then examined whether the rise in [Ca2+] i of into two groups. One group was treated with 0.2 mg PMNL after the in vitro incubation in high glucose amlodipine/g b.w./day for 3 days while the other group media affects their phagocytosis. Table 1 shows that did not receive amlodipine but was followed for an with the rise in [Ca2+] i of 18±0.32 nM after 30 min additional 3 days as well. We also examined the effect of incubation, phagocytosis (76±1.9 mg oil/107 of daily s.c. injection of normal rats with 0.20 mg of PMNL/min) was significantly (P<0.01) impaired and amlodipine/g b.w./day for 3 and 12 days on [Ca2+] i this derangement was more marked (66±2.7 mg oil/107 and phagocytosis of PMNL. PMNL) after 60 min of incubation and at a time when Systolic blood pressure was measured before and at the increment in [Ca2+] i of PMNL was 35±2.6 nM. 3, 6, 9, and 12 days after the injection of streptozotocin The data on the incubation of PMNL for 1 h in media using the tail-cuff method with an electrosphygmoman-containing 30 mM glucose with and without 4 mM ometer and physiograph recorder MK-III (Narco Bio-amlodipine are also shown in Table 1 . Amlodipine Systems, Houston, TX ).
The concentrations of calcium in serum were determined by Perkin Elmer spectrophotometer model 505, those of phosphorus and creatinine by an autoanalyzer ( Technicon Inc., Tarrytown, NY, USA); and of blood glucose by a Accu-Check Advantage ( Boehringer Mannheim, Indianapolis, IN, USA). Serum parathyroid hormone (PTH ) levels were estimated with radioisotopic assay (Intact PTH-Nichols Institutes Diagnostics, San Juan Capistrano, CA, USA). The normal value of PTH is 10 to 65 pg/ml. Statistical analysis was done using paired and unpaired t-test, and the relationship between two variables was determined by the correlation coefficient. Data are reported as mean ±1 SE. The animals did not loose weight during the first 3 in vitro. Each column represents the mean of six studies and brackets denote ±1 SE.
days of diabetes. However, there was a tendency for a Figure 5 and caused a significant improvement in their phagocytosis ( 77±0.52 mg oil/107 PMNL/min). However, shows an inverse and significant relationship between phagocytosis of PMNL and their [Ca2+] i (r=0.67, the phagocytic activity of the PMNL remained modestly below normal. We therefore examined whether P<0.01) and with blood glucose levels as well (r= 0.82, P<0.01). The data in this figure are derived from amlodipine, by itself, depresses phagocytosis of PMNL; the incubation of PMNL in a media containing low all studies where these three parameters were measured simultaneously. glucose (5.5 mM ) and 4 mM amlodipine for 1 h was not associated with a reduction in their [Ca2+] i or in The reduced phagocytic ability of the PMNL became apparent after 1 day of hyperglycaemia, and the elevatheir phagocytosis, ( Table 1) .
The in vivo studies demonstrated that after the tion in [Ca2+] i and the impairment in phagocytosis progressed after 2 and 3 days of hyperglycaemia injection of streptozotocin and the rise in the blood levels of glucose, the basal levels of [Ca2+] i of PMNL (Figure 6 ). One day of amlodipine therapy did not prevent the rise in [Ca2+] i of PMNL nor the impairment also increased. This effect was observed within one day of hyperglycaemia. i of PMNL and blood levels of glucose in all rats studies after 1, 2, 3, and 12 days. There was was observed after 2 days of amlodipine therapy (P<0.01). By the third day of amlodipine administraa significant and direct correlation between these two parameters (r=0.88, P<0.01).
tion, the levels of [Ca2+] i of the PMNL were normal and the values of their phagocytosis was markedly The streptozotocin-induced hyperglycaemia and the of the PMNL of the diabetic rats were normal of six to seven studies of diabetic rats and 21 studies of normal rats and the levels of their phagocytosis were close to but and brackets denote ±1 SE. still lower than normal values as compared with the values in diabetic animals that did not receive amlodipamlodipine did not cause a fall in their systolic blood ine ( Figure 7) . In this latter group of animals, the pressure ( Figure 9 ). values of phagocytosis of PMNLs were inversely (r= 0.95, P<0.01) and those of [Ca2+] i were directly (r= 0.85, P<0.01) correlated to the blood levels of glucose.
Discussion
Treatment of normal rats with amlodipine for 3 or 12 days did not cause a significant change in [Ca2+] i ( 3 days: 90±44 vs 92±3.3 nM; 12 days: 92±1.3 vs Previous studies have shown that an elevation in the basal levels of [Ca2+] i of PMNL found in a variety of 93±2.2 nM ) or in their phagocytosis (3 days: 88±2.1 vs 87±2.3 mg oil/107 PMNL/min; 12 days: 93±0.9 vs clinical conditions such as chronic renal failure [16, 17] , phosphate depletion [18] or diabetes mellitus [9] is 92±2.2 mg oil/107 PMNL/min.
Treatment with amlodipine not only prevented the associated with impaired phagocytosis. These observations led to the proposal that the high basal levels of hyperglycemia-induced rise in [Ca2+] i of PMNL and improved the impairment in their phagocytosis but [Ca2+] i is responsible, in major part, for the impairment in the phagocytic property of the PMNL [9, [16] [17] [18] . also reversed the already established derangements induced after 3 or 12 days of hyperglycaemia. Indeed, Support for this notion was provided by the finding that normalization [Ca2+] i of PMNL in chronic renal the treatment of 3 days or 12 days diabetic rats with amlodipine for 3 days normalized [Ca2+] i of PMNL failure [17, 19] or in phosphate depletion [18 ] by treatment with calcium channel blockers prevented and and markedly improved their phagocytosis (P<0.01) ( Figure 8 ). The treatment of the diabetic rats with reversed the impairment in phagocytosis. [20 ] . However, Simchowitz and Spilberg [21] ship between basal levels of [Ca2+] i of PMNL and blood glucose
showed that 45Ca influx into PMNL is inhibited by obtained in the same animals are shown in the lower panel.
verapamil. Alexiewicz et al. [19] and Hörl et al. [22] also reported that treatment of dialysis patients with nifedipine or verapamil was followed by restoration of The results of the present studies demonstrate that the calcium channel blocker, amlodipine, prevented the elevated basal levels of [Ca2+] i of their PMNL toward normal values. These observations and those the glucose-induced rise in [Ca2+] i and significantly ameliorated the associated impairment in phagocytosis of the present study suggest that either L-type calcium channels do exist in PMNL or other types of calcium of PMNL incubated in a high glucose media. The effect of amlodipine on the glucose-induced rise in channels inhibitable by verapamil, nifedipine or amlodipine may be present in PMNL [23 ] .
is not a drug specific but is also produced by other calcium channel blockers such as verapamil or
The data obtained in the in vivo experiments of the present study demonstrate that even modest hypernifedipine [12 ] . This class of drugs is effective in this regard because the exposure of PMNL to a high glycaemia that occurs after 1 day of diabetes mellitus is associated with a rise in basal levels of [Ca2+] i of glucose concentration results in activation of calcium channels in these cells with consequent increased cal-PMNL and with impairment in their phagocytic ability.
These derangements worsen as the blood levels of cium entry into them [12 ] . This proposal implies that PMNL possess L-type calcium channels that are glucose rise further and/or the duration of diabetes increases. Indeed, there was a significant direct correlainhibitable by calcium channel blockers. Certain data i of PMNL, phagocytosis and blood glucose levels in 21 normal rats (%), and of 3 and 12 days diabetic rats (&) which were then treated for 3 days with amlodipine (u). Each column represents the mean of six studies of diabetic rats and brackets denote ±1 SE. tion between the degree of hyperglycaemia and the therapy or hypoglycaemic agents was associated with significant improvement in these abnormalities [9, 28, basal levels of [Ca2+] i of PMNL. Also the impairment in phagocytosis of the PMNL inversely and signific-29], as well as normalization of the elevated levels of
[Ca2+] i in the PMNL [9 ] . If the high basal levels of antly correlated with the blood levels of glucose and with the basal levels of their [Ca2+] i . These observations [Ca2+] i in the PMNL of diabetic patients play an important role in the genesis of the derangements in are similar to those found in humans with diabetes mellitus [9] . It should be mentioned that our rats had chemotaxis, adherence and bacterial killing by these cells, as it does in their impaired phagocytosis, therapy the equivalent of type I diabetes mellitus while the data on the PMNL in humans were obtained in with calcium channel blockers may prove useful in combating all these derangements and in reducing the patients with type II diabetes mellitus. It appears, therefore, that the basal levels of [Ca2+] i of PMNL risk of infection even in poorly controlled diabetics. and the impairment in their phagocytosis occur in both types of diabetes mellitus.
